{"id":"https://openalex.org/W7224828717","doi":"https://doi.org/10.6084/m9.figshare.34868045","title":"Soluble epoxide hydrolase inhibitors: structural features, design strategies, and SAR insights","display_name":"Soluble epoxide hydrolase inhibitors: structural features, design strategies, and SAR insights","publication_year":2026,"publication_date":"2026-10-30","ids":{"openalex":"https://openalex.org/W7224828717","doi":"https://doi.org/10.6084/m9.figshare.34868045"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.34868045","doi":"https://doi.org/10.6084/m9.figshare.34868045","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34868045","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.34868045","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072652622","display_name":"Dipanjan Karati","orcid":"https://orcid.org/0000-0003-0734-6015","observed_orcids":["https://orcid.org/0000-0003-0734-6015"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dipanjan Karati","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160201516","display_name":"Koninika Mitra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koninika Mitra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160231518","display_name":"Srinjoy Banerjee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Srinjoy Banerjee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5138994790","display_name":"Samiksha Jana","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samiksha Jana","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.75918885,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/soluble-epoxide-hydrolase-inhibitors","display_name":"soluble epoxide hydrolase inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/soluble-epoxide-hydrolase","display_name":"soluble epoxide hydrolase","score":0.9700000286102295},{"id":"https://openalex.org/keywords/epoxyeicosatrienoic-acids","display_name":"epoxyeicosatrienoic acids","score":0.9879999756813049},{"id":"https://openalex.org/keywords/dihydroxyeicosatrienoic-acids","display_name":"dihydroxyeicosatrienoic acids","score":0.9890000224113464},{"id":"https://openalex.org/keywords/anti-inflammatory-agents","display_name":"anti-inflammatory agents","score":0.7639999985694885},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8389999866485596},{"id":"https://openalex.org/keywords/pharmacophore","display_name":"pharmacophore","score":0.7710000276565552},{"id":"https://openalex.org/keywords/urea-analogues","display_name":"urea analogues","score":0.6949999928474426},{"id":"https://openalex.org/keywords/amide-analogues","display_name":"amide analogues","score":0.9419999718666077},{"id":"https://openalex.org/keywords/drug-likeness","display_name":"drug-likeness","score":0.875},{"id":"https://openalex.org/keywords/admet-properties","display_name":"ADMET properties","score":0.9190000295639038},{"id":"https://openalex.org/keywords/inflammatory-diseases","display_name":"inflammatory diseases","score":0.45500001311302185}],"concepts":[{"id":"https://openalex.org/C18605011","wikidata":"https://www.wikidata.org/wiki/Q17916975","display_name":"Epoxide hydrolase 2","level":3,"score":0.8928999900817871},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.8497999906539917},{"id":"https://openalex.org/C101819947","wikidata":"https://www.wikidata.org/wiki/Q87444516","display_name":"Epoxide hydrolase","level":4,"score":0.7121000289916992},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.6489999890327454},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.593500018119812},{"id":"https://openalex.org/C2780120296","wikidata":"https://www.wikidata.org/wiki/Q96286","display_name":"Hydrolase","level":3,"score":0.585099995136261},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5828999876976013},{"id":"https://openalex.org/C2776920199","wikidata":"https://www.wikidata.org/wiki/Q408028","display_name":"Epoxide","level":3,"score":0.5113999843597412},{"id":"https://openalex.org/C2780900081","wikidata":"https://www.wikidata.org/wiki/Q7454849","display_name":"Serine hydrolase","level":4,"score":0.41370001435279846},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3427000045776367},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.3244999945163727},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.3165999948978424},{"id":"https://openalex.org/C41183919","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Active site","level":3,"score":0.31439998745918274},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.29989999532699585},{"id":"https://openalex.org/C553450214","wikidata":"https://www.wikidata.org/wiki/Q851162","display_name":"Biosynthesis","level":3,"score":0.2919999957084656},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.27799999713897705},{"id":"https://openalex.org/C89429830","wikidata":"https://www.wikidata.org/wiki/Q735710","display_name":"Scaffold","level":2,"score":0.2703000009059906},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.2671000063419342},{"id":"https://openalex.org/C192989942","wikidata":"https://www.wikidata.org/wiki/Q68685","display_name":"Metabolic pathway","level":3,"score":0.2637999951839447},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26010000705718994},{"id":"https://openalex.org/C196032511","wikidata":"https://www.wikidata.org/wiki/Q375795","display_name":"Glycoside hydrolase","level":3,"score":0.2597000002861023},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.2581999897956848},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.25589999556541443}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.34868045","doi":"https://doi.org/10.6084/m9.figshare.34868045","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34868045","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.6084/m9.figshare.34868045.v1","doi":"https://doi.org/10.6084/m9.figshare.34868045.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34868045.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.34868045","doi":"https://doi.org/10.6084/m9.figshare.34868045","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34868045","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2998633660","https://openalex.org/W4223503791","https://openalex.org/W3106851243","https://openalex.org/W3115914200","https://openalex.org/W3164790444","https://openalex.org/W2348000787","https://openalex.org/W3201334326","https://openalex.org/W2115570647","https://openalex.org/W2145630011","https://openalex.org/W4200549567"],"abstract_inverted_index":{"Several":[0],"pathological":[1],"disorders":[2,10],"including":[3,145],"inflammatory":[4,46],"disorders,":[5],"cardiovascular,":[6],"metabolic":[7],"and":[8,24,32,38,132,139,153,165,168,174,177],"neurodegenerative":[9],"have":[11,63,118,125,158],"increased":[12],"at":[13],"an":[14,76,110,127],"alarming":[15],"rate":[16],"due":[17],"to":[18,40,90,100],"our":[19],"lifestyle":[20],"changes,":[21],"pollution,":[22],"diet":[23],"various":[25],"other":[26,154],"reasons.":[27],"Different":[28],"classes":[29,146],"of":[30,45,51,97,104,115,135,147],"Anti-inflammatory":[31],"Anti-cancer":[33],"drugs":[34,52],"must":[35],"be":[36],"designed":[37],"modified":[39],"counteract":[41],"the":[42,54,102,113,130,162,175],"rapid":[43],"growth":[44],"disorders.":[47],"One":[48],"such":[49],"class":[50],"is":[53,75,99],"Soluble":[55,71],"Epoxide":[56,72],"Hydrolase":[57,73],"Inhibitor":[58],"(sEHI)":[59],"about":[60,161],"which":[61,78,87,117],"we":[62,124],"articulated":[64],"in":[65,67,112],"detail":[66],"this":[68,122],"review":[69],"work.":[70],"(sEH)":[74],"enzyme":[77],"converts":[79],"Epoxyeicosatrienoic":[80],"acids":[81,85],"(EET\u2019s)":[82],"into":[83,106,129],"Dihydroxyeicosatrienoic":[84],"(DHET\u2019s)":[86],"are":[88],"said":[89],"possess":[91],"pro-inflammatory":[92],"properties.":[93,120],"The":[94],"main":[95],"aim":[96],"sEHI\u2019s":[98,148],"stop":[101],"conversion":[103],"EET\u2019s":[105,116],"DHET\u2019s":[107],"thereby":[108],"causing":[109],"increase":[111],"level":[114],"anti-inflammatory":[119],"In":[121],"study,":[123],"provided":[126],"insight":[128],"structural":[131],"catalytic":[133],"features":[134],"sEHI\u2019s,":[136],"their":[137,142],"pharmacophores":[138],"design":[140],"principles,":[141],"scaffold":[143],"evolution":[144],"like":[149],"Ureas,":[150],"Amides,":[151],"Carbamates":[152],"non-urea":[155],"analogues.":[156],"We":[157],"also":[159],"discussed":[160],"drug-likeness,":[163],"ADMET":[164],"optimization":[166],"challenges":[167],"lastly":[169],"medicinal":[170],"outlooks,":[171],"future":[172],"directives":[173],"pre-clinical":[176],"clinical":[178],"trials.":[179]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-31T00:00:00"}